![Boston_H_color[33632]_edited.png](https://static.wixstatic.com/media/e60c5c_0b72738a80554196840094a8e387c5ed~mv2.png/v1/fill/w_338,h_77,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/Boston_H_color%5B33632%5D_edited.png)
Live Streaming Virtual CNE Symposium
Live Q&A With David C. Fajgenbaum, MD, MBA, MSc Assistant Professor of Medicine Division of Translational Medicine and Human Genetics University of Pennsylvania Associate Director, Patient Impact Penn Orphan Disease Center Founding Director Center for Cytokine Storm Treatment & Laboratory Co-Founder and Executive Director Castleman Disease Collaborative Network Philadelphia, PA
Tuesday, April 13, 2021 6:30 pm – 7:45 pm ET
Held in collaboration with the Boston Oncology Nursing Society chapter and the Castleman Disease Collaborative Network.
This activity is jointly provided by Global Education Group and Paradigm Medical Communications, LLC. Nursing Continuing Education Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity for 1.25 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Join BONS for our upcoming Bookclub! We are raffling copies of the book at this event as we honor our speaker, David C. Fajgenbaum, MD, MBA, MSc and author or Chasing My Cure.
Nurse Practitioner Continuing Education
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Global Education Group and Paradigm Medical Communications, LLC. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 1.25 contact hours (which includes 0.1 hour(s) of pharmacology).
This activity is supported by an educational grant from EUSA Pharma.